Status:
COMPLETED
Comparison of Desensitizing Materials
Lead Sponsor:
Nourah Mulfi Aljasser
Conditions:
Dentin Hypersensitivity
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
To compare the efficacy of two commercially available in-office desensitizing agents (Fluoraphat Pro and VivaSens®), in the treatment of dentinal hypersensitivity.
Detailed Description
Dentine hypersensitivity (DH) is a condition that occurs in non-pathological, non-defective teeth and is defined as "a short, sharp pain in response to stimuli, typically thermal, evaporative, tactile...
Eligibility Criteria
Inclusion
- Males and females aged between 18 and 50 years
- Patient should have at least 2 teeth with dentinal hypersensitivity
- Sound tooth structure
- Willingness to participate in the study
Exclusion
- Gingival recession
- Caries
- Non-carious lesions (attrition, abrasion, erosion, abfraction)
- Teeth restored with dental filling
- Fractured or cracked tooth
- Microleakage
Key Trial Info
Start Date :
January 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04527159
Start Date
January 6 2019
End Date
February 24 2020
Last Update
September 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nourah Aljasser
Riyadh, Saudi Arabia, 13311